Informed consent and phase IV non-interventional drug research

Current Medical Research and Opinion

Volumn 27, Issue 3, 2011, Pages 513-518

  Bernabe, Rosemarie D C ^a   Van Thiel, Ghislaine J M W ^a   Van Delden, Johannes J M ^a   Raaijmakers, Jan A M ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b GLAXOSMITHKLINE   (Netherlands)

Author keywords

Consent forms; Informedconsent; Noninterventional studies; Observational studies; Phase IV; Research ethics

Indexed keywords

DRUG MARKETING; DRUG RESEARCH; INFORMED CONSENT; MEDICAL ETHICS; PHASE 4 CLINICAL TRIAL (TOPIC); REVIEW;

CLINICAL TRIALS, PHASE IV AS TOPIC; CONSENT FORMS; DRUG UTILIZATION; HUMANS; INFORMED CONSENT; OBSERVATION; PERSONAL AUTONOMY; PHARMACEUTICAL PREPARATIONS; PRODUCT SURVEILLANCE, POSTMARKETING; RESEARCH; RISK ASSESSMENT;

EID: 79951635381     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2010.546393     Document Type: Review

References (28)

1. International Conference on Harmonisation. General considerations for clinical trials E8. Geneva: International Federation of Pharmaceutical Manufacturers and Associations 1997 [cited September, 2009]. Available from http://www. ich.org/cache/compo/276-254-1.html
2. Levine RJ. Informed consent: consent issues in human research. In: Garrad Post, S. ed. Encyclopedia of Bioethics, 3rd edn. Farmington Hills, MI: Gale/ MacMillan Reference Library, 2004:1280-9
3. Manson NC, O'Neill O. Rethinking Informed Consent in Bioethics. Cambridge, New York: Cambridge University, 2007
4. European Medicines Agency. The European Medicines Agency road map to 2015: the agency's contribution to science, medicine, health (draft for public consultation). London: European Medicines Agency; 2010 [cited March, 2010]. Available from: www.ema.europa.eu/pdfs/general/direct/ directory/29989509en.pdf
5. European Parliament. Directive 2001/20/EC on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. Publications Office of the European Union; 2001 [cited October, 2008]. Available from: http://eur-lex.europa.eu/smartapi/ cgi/sga-doc?smartapi!celexapi!prod!CELEXnumdoc&lg¼en& model¼guicheti &numdoc¼32001L0020
6. Eudralex Volume 9A. In: McCully S. Non-interventional Studies. Contin: Compliance Healthcheck Consulting UK; 2010 [cited 2010 Feb 1]. Available from: http://www.chcuk.co.uk/nisresources.html
7. McCully S. Non-interventional studies. Contin: Compliance Healthcheck Consulting UK; 2009 [cited 2010 Feb 1]. Available from: http://www.chcuk. co.uk/nisresources.html
8. International Conference on Harmonisation. Pharmacovigilance planning E2E. Geneva: International Federation of Pharmaceutical Manufacturers and Associations 2004 [cited September, 2009]. Available from http://www. ich.org/cache/compo/475-272-1.html#E2E
9. Cuttini M, Saracci R. Commentary: Can we facilitate the ethical approval of international observational studies? Int J Epidemiol 2009;38:1108-9
10. Buckley B, Murphy AW, Byrne M, et al. Selection bias resulting from the requirement for prior consent in observational research: a community cohort of people with ischaemic heart disease. Heart 2007;93:1116-20 (Pubitemid 47310993)
11. Al-Shahi R, Vousden C, Warlow C. Bias from requiring explicit consent from all participants in observational research: prospective, population based study. BMJ 2005;331:942
12. Lemaire F. Informed consent and studies of a quality improvement program. JAMA 2008;300:1762-3
13. Zoellner P, Kapp H, Smola H. A prospective, open-label study to assess the clinical performance of a foam dressing in the management of chronic wounds. Ostomy Wound Manage 2006;52:34-2
14. Tu JV, Willison DJ, Silver FL, et al. Impracticability of informed consent in the Registry of the Canadian Stroke Network. N Engl J Med 2004;350:1414-21 (Pubitemid 38419995)
15. Miller FG, Emanuel EJ. Quality-improvement research and informed consent. N Engl J Med 2008;358:765-7 (Pubitemid 351281639)
16. Feinberg J. Harmless Wrongdoing. New York: Oxford University, 1990
17. Feinberg J. Offense to Others. New York: Oxford University, 1985
18. Beauchamp T, Childress J. Principles of Biomedical Ethics 6th edn. New York: Oxford University, 2008
19. Beyleveld D, Brownsword R. Consent in the Law. Oxford: Hart, 2007
20. Bielby P. Competence and vulnerability in biomedical research. Dordrecht: Springer, 2008
21. Capron AM. Legal and regulatory standards of informed consent in research. In: Emanuel E, Grady C, Crouch RA, et al., eds. The Oxford Textbook of Clinical Research Ethics. New York: Oxford University, 2008:613-32
22. Burgess MM. Proposing modesty for informed consent. Soc Sci Med 2007;65:2284-95 (Pubitemid 350087421)
23. Hansson MO. Balancing the quality of consent. J Med Ethics 1998;24:182-7 (Pubitemid 28274484)
24. Flory J, Wendler D, Emanuel E. Empirical issues in informed consent for research. In: Emanuel E, Grady C, Crouch RA, et al., eds. The Oxford Textbook of Clinical Research Ethics. New York: Oxford University, 2008:645-60
25. Appelbaum PS, Lidz CW, Grisso T. Therapeutic misconception in clinical research: frequency and risk factors. IRB 2004;26:1-8 (Pubitemid 41585058)
26. Kavasery R, Maru DS, Sylla LN, et al. A prospective controlled trial of routine opt-out HIV testing in a men's jail. PLoS One 2009;4:e8056
27. Hewison J, Haines A. Overcoming barriers to recruitment in health research. BMJ 2006;333:300-2
28. Clark AM, Findlay IN. Attaining adequate consent for the use of electronic patient records: an opt-out strategy to reconcile individuals' rights and public benefit. Public Health 2005;119:1003-10 (Pubitemid 41487586)